189 related articles for article (PubMed ID: 2698714)
1. [Non-digitalis inotropic agents in the treatment of congestive heart insufficiency].
Correia JF
Rev Port Cardiol; 1989 Jun; 8(6):473-81. PubMed ID: 2698714
[TBL] [Abstract][Full Text] [Related]
2. [Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors].
Stefenelli T
Acta Med Austriaca; 1991; 18(4):81-5. PubMed ID: 1763582
[TBL] [Abstract][Full Text] [Related]
3. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
4. [Positive inotropic substances--therapeutic perspectives].
Erdmann E; Böhm M
Z Kardiol; 1991; 80 Suppl 8():57-62. PubMed ID: 1796636
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of inodilators.
Dei Cas L; Metra M; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of heart failure: positive inotropic agents.
Cross JA
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549
[TBL] [Abstract][Full Text] [Related]
7. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
Chatterjee K; Wolfe CL; DeMarco T
Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to the development of positive inotropic agents for chronic heart failure.
Packer M
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of calcium-sensitizing agents.
Vegh A; Papp JG; Udvary E; Kaszala K
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
[TBL] [Abstract][Full Text] [Related]
10. [Positive inotropic substances. Possible use in heart failure in the aged].
Michel D
Fortschr Med; 1991 Aug; 109(25):496-9. PubMed ID: 1937336
[TBL] [Abstract][Full Text] [Related]
11. [Inotropic drugs in treatment of heart failure--advantages and adverse reactions].
Witkowska M
Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):936-40. PubMed ID: 1300581
[TBL] [Abstract][Full Text] [Related]
12. Vasodilators and inotropic agents in the treatment of congestive heart failure.
Francis GS
Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
[TBL] [Abstract][Full Text] [Related]
13. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
[No Abstract] [Full Text] [Related]
14. The future of inotropic drugs in clinical practice.
Smith TW
Eur Heart J; 1982 Dec; 3 Suppl D():149-56. PubMed ID: 6130948
[No Abstract] [Full Text] [Related]
15. [Drug therapy of heart failure].
Follath F
Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
[TBL] [Abstract][Full Text] [Related]
16. [New inotropic agents in the treatment of congestive heart failure].
Hutton I; McKillop J; Clark R; Martin W; Tweddel A
Ter Arkh; 1982; 54(11):98-101. PubMed ID: 7157176
[No Abstract] [Full Text] [Related]
17. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
Petein M; Levine TB; Cohn JN
Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
[TBL] [Abstract][Full Text] [Related]
18. Cardiac drugs: new inotropes.
Kelleher RM
Crit Care Nurs Clin North Am; 1989 Jun; 1(2):391-7. PubMed ID: 2818883
[TBL] [Abstract][Full Text] [Related]
19. Is the efficacy of positive inotropic drugs limited to symptomatic improvement?
Baumann G; Felix SB
Herz; 1991 Sep; 16 Spec No 1():304-13. PubMed ID: 1820297
[TBL] [Abstract][Full Text] [Related]
20. Present and future trends in research and clinical applications of inodilators.
Cargnelli G; Piovan D; Bova S; Padrini R; Ferrari M
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S124-32. PubMed ID: 2483438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
